雄激素剥夺治疗对中危前列腺癌预后的影响：基于 RTOG9408 随机临床试验的二次分析，按有利或不利分组。
Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial.
机构信息
Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.
Department of Radiation Oncology, University of Michigan, Ann Arbor.
出版信息
JAMA Netw Open. 2020 Sep 1;3(9):e2015083. doi: 10.1001/jamanetworkopen.2020.15083.
Abstract
This secondary analysis of a randomized clinical trial examines the effect of androgen deprivation therapy (ADT) during radiotherapy in patients who were classified as having either favorable intermediate-risk or unfavorable intermediate-risk prostate cancer.
摘要
本二次分析研究了随机临床试验，探讨了在被分类为具有有利中危或不利中危前列腺癌的患者中，放射治疗期间雄激素剥夺治疗（ADT）的效果。
Zotero 插件